To:
Spin...@yahoogroups.com,
zerh...@od.nih.gov,
Spin...@yahoogroups.com,
kshe...@calea.org,
fit...@gmail.com,
patrick.f...@usdoj.gov,
model...@sbcglobal.net,
jdr...@nejm.org,
let...@courant.com,
Jgerb...@cdc.gov,
len...@courant.com,
michae...@po.state.ct.us,
con...@po.state.ct.us,
executiv...@nytimes.com, managing-
edi...@nytimes.com,
news...@nytimes.com,
the-...@nytimes.com,
biz...@nytimes.com,
for...@nytimes.com,
me...@nytimes.com,
nati...@nytimes.com,
dv...@cdc.gov,
brigidc...@optonline.net,
tr...@hotmail.com,
ubi...@courant.com,
ma...@concentric.net,
camp...@courant.com,
jhorn...@fff.org,
thomas...@usdoj.gov,
thoma...@po.state.ct.us,
kur...@washpost.com,
georg...@washpost.com,
hor...@courant.com,
commissi...@po.state.ct.us,
cohen...@aol.com,
FalN...@aol.com,
brans...@comcast.net,
vts...@comcast.net,
o...@po.state.ct.us,
da...@davila-dilzer.com,
scott....@po.state.ct.us,
govern...@po.state.ct.us,
attorney...@po.state.ct.us,
randall...@usdoj.gov
Cc:
fra...@ucia.gov,
dr-ahma...@president.ir,
eugener...@washpost.com,
hor...@courant.com,
bmi...@newstimes.com,
tr...@hotmail.com,
rast...@aol.com,
billc...@gmail.com,
thomas...@usdoj.gov,
amcg...@rms-law.com,
rjmu...@aol.com,
paulcrai...@yahoo.com,
sidney_b...@yahoo.com,
criminal...@usdoj.gov,
karla.d...@usdoj.gov,
christophe...@usdoj.gov
Subject: [SpinLyme] UPDATE----IDSA's Homicide-Charges Hysteria
Date: May 14, 2008 6:06 AM
IDSA Cowards are all about OspA (The best defense is a good offense:
Pretend OspA
is still a vaccine)
http://www.actionlyme.org/MCSWEEGAN_AND_DUMB_EUROPEANS.html
(Um, no Ed, we demonized the vaccine because of the immune suppression/
dyregulation
outcomes and what appeared to be an activation of asymptomatic Lyme:
http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2_11.pdf
See page 5 of that .pdf.
"WE DO BELIEVE LYMERIX IS EFFECTIVE AT PREVENTING ASYMPTOMATIC LYME,
BUT RATHER,
TURNING ASYMPTOMATIC CASES INTO SYMPTOMATIC CASES." )
http://www.topix.net/forum/source/hartford-courant/TBNICARUEUQ9VLTEV/p3
By Lynn Shepler, MD, JD:
http://www.topix.net/forum/source/hartford-courant/TBNICARUEUQ9VLTEV/p3
I am utterly skeptical of the claims made by Dr. Poretz. It is well
known that those
involved in the IDSA guidelines are also involved in promoting or
creating Lyme
disease vaccine products, and have, or are continuing to consult to
pharmaceutical
companies involved in Lyme disease vaccines. In order to successfully
conduct a
Lyme disease vaccine trial, there are certain assumptions that need to
be written
in stone within the medical community --- for example,(1) that
patients do not routinely
receive, as a standard of medical practice, antibiotic prophylaxis at
the time of
tick bite (particularly in Lyme endemic areas); and (2) that there is
an assumption
that no patient is asymptomatically infected or subclinically infected
at the time
of inoculation with the potential Lyme disease vaccine (i.e., and that
all bacteria
are easily and totally killed off at the time of infection). If these
assumptions,
which are part of the guidelines, are not in place --- it would not be
possible
to conduct new Lyme disease vaccine trials. All patients in endemic
areas (where
Lyme disease vaccine trials would, of course, be conducted) would be
getting antibioitcs
at the time of tick bite (abrogating the need for a vaccine and making
it as an
intervnetion outside the accepted medical standard of practice). And,
speaking to
the second point --- it would be impossible to know how successful or
unsuccessful
a Lyme vaccine is if one acknowledges the existence of chronic
borreliosis infection
if one is not certain, in the first place, whether the vaccine subject
is, or is
not infected..(Note: Borrelia burgdorferi is the organism that causes
Lyme disease.
Lyme disease is also called "borreliosis.").
Dr. Poretz also does not mention that there are those on the IDSA
guidelines committee
that hold patents on Lyme disease antigens, who could profit from
their patents
being used as antigens in Lyme disease vaccines, or antibody test kits
through licensing
to pharmaceutical companies. The universities where these scientists
made the patent
would also financially benefit. This is a way that some academic
physicians have
become enormously wealthy --- through the licensing of their patents.
For example,
at one time, Yale Univeristy projected it would make $10 million per
year from the
previous Lyme disease vaccine (LYMErix), which was ultimately pulled
from the market
due to adverse effects. Some lawsuits from the LYMErix debacle still
have not reached
settlement ---- another conflict of interest, where changing the
guidelines could
open up the risk of increased financial liability for the harms
associated with
the first vaccine.
In my view, the issues surrounding a Lyme vaccine (past and future) is
what the
fight is about. And this is why the "scientists" adamanatly do not
want
to acknowledge the existence of chronic borreliosis (chronic Lyme
disease) despite
evidence to the contrary. This has caused enormous suffering and
hardship to many
individuals who are infected with this potentially devasting disease.
In addition,.IDSA has continued to lobby against federally funded
research that
would help bring to light the mechanisms of chronic infection, and
what interventions
might ultimately be offered to chornically sick patients. It is
unusual ot see a
medical society fight against scientific progress concerning a major
disease.
We salute Connecticut Attorney General Blumenthal and his staff for
the intervention
they have made in trying to halt this travesty.
-----Original Message-----
>From: Kathleen <
janmu...@earthlink.net>
>Sent: May 12, 2008 4:11 AM
>Subject: [SpinLyme] IDSA's Homicide-Charges Hysteria
>
>They're clearly hysterical.
>(See the opinion page by IDSA in the Courant, below, although it's not opinion
but scientific fraud and racketeering)
>=======================================================
>
http://www.topix.net/forum/source/hartford-courant/TBNICARUEUQ9VLTEV#lastPost
>
>"The Infectious Diseases Society of America's Lyme disease guidelines
recommend generic drugs and generic diagnostic tests. Panel members
had no financial
interests that could have affected, or been affected by,
recommendations in the
guidelines."
>---
>
>This is a totally false statement. There are still-outstanding lawsuits against
Gary Wormser over the last OspA trials, over which the diagnostic
standard for Lyme
was changed in 1994 at the Dearborn, MI conference:
>
http://www.actionlyme.org/CRYMEDISEASE_CHP3_B.htm
>The blood test definition of Lyme disease was changed from that of a Relapsing
Fever Borreliosis to a late arthritis in a knee by Allen Steere in
Europe.
>
>The new, 1994, false standard - leaving out almost all IgM antibodies, which
at one time was the marker of ongoing infection by none other than
Allen Steere
and adopted by the CDC - only detects late Lyme arthritis in a knee,
presumably
caused by a genetically-linked hypersensitivity reaction and not found
in the majority
of the Caucasian population.
>
>These crooks changed the definition of the disease to suit the false positive
outcomes of LYMErix and ImmuLyme and now they're doing it in self-
defense of
lawsuits, since they threw out the vaccine failure data- the data
which proves that
the New Great Imitator outcomes of Lyme disease are the same as
LYMErix disease-
the immune suppression caused by the shed Osps:
>
http://www.actionlyme.org/BIOWEAPONEERS_CORIXA_YALE_TLRS.htm
>
>Thirdly, Gary Wormser and Allen Steere still consult for Baxter, which means:
part of their defense against causing LYMErix Disease, is to pretend
OspA is still
a vaccine:
>
http://www.actionlyme.org/WORMSER_INSISTS_LYME_A_KNEE_DISEASE.htm
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>|
>Report Abuse
>|
>#2
>26 min ago
>
>This IDSA idiot may think he is fooling the public and the rest of the medical
world, but the AG knows what happened at Dearborn, as I explained also
to the 2001
FDA LYMErix Vaccine Committee:
>
http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2_11.pdf
>
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
>
>These idiots are not getting away with this. In 2000, Gary Wormser published
an article explaining how LYMErix or ImmuLyme suppressed the immune
system:
>
http://www.ncbi.nlm.nih.gov/pubmed/10865170?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
>Modulation of lymphocyte proliferative responses by a canine Lyme disease vaccine
of recombinant outer surface protein A (OspA).
>
>Chiao JW, Villalon P, Schwartz I,***Wormser GP.***
>
>Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
>
>The modulation of human lymphocyte proliferative responses was demonstrated
with a recombinant outer surface protein A (OspA) vaccine preparation
for the prevention
>of Borrelia burgdorferi infection.***After exposure to either the unaltered
vaccine preparation or OspA prepared in saline, normal lymphocyte
responses to the
mitogens concanavalin A, phytohemagglutinin-M or pokeweed mitogen, or
the antigen
BCG were consistently reduced.*** Whole cell extracts of B.
burgdorferi also modulated
immune
>responses but required a much greater quantity of protein than needed for the
OspA
>preparation. The magnitude of modulation was directly dependent on the quantity
>of OspA.*** OspA interferes with the response of lymphocytes to proliferative
stimuli including a blocking of cell cycle phase progression.***
Future studies
designed to delete the particular region or component of the OspA
molecule responsible
for this effect may lead to improved vaccine preparations.
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>
>
http://www.journals.uchicago.edu/CID/journal/issues/v43n9/40897/40897.html?erFrom=3339103491423400595Guest
>
>"Potential conflicts of interest. G.P.W.[Gary Wormser] has received consulting
fees from Baxter and research support from Immunetics, and he is a
founder of Diaspex,
a company that does not offer products or services. R.J.D.[Ray
Dattwyler] has served
as a speaker for Pfizer and is part owner of Biopeptides, a biotech
company that
develops vaccines and laboratory diagnostics, including products for
Borrelia burgdorferi.
J.J.H.[John Halperin] has served as an expert witness on behalf of
Lymerix (GlaxoSmithKline).
A.C.S.[Allen Steere] has received consulting fees from Baxter. P.J.K.
has a patent
pending with a university on a babesiosis diagnostic procedure that is
not yet on
the market. All other authors: no conflicts."
>
>OspA- The best defense is a good offense
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>|
>Report Abuse
>|
>#4
>20 min ago
>
>
http://www.actionlyme.org/LYME_IS_A_PERMANENT_BRAIN_INFECTION.htm
>
>If these IDSA crooks have all published that Lyme is an incurable brain disease,
as you can see from the reports in that link, then we wonder how it
could be only
a late arthritis in a knee that needs no antibiotic treatment.
Especially when all
througout history, all tick borne borrelia were well-known to be
permanent, incurable
brain infections?
>
http://www.actionlyme.org/RICOCHRON.htm
>
>We wonder how it is that Kaiser-Permanente is *still* training MDs at New York
Medical College, where the ALDF.com cabal was set up in 1990:
>
http://www.actionlyme.org/CONNOLLY_FISH_WEINSTEIN.htm
>These are the OPMC's "experts"
>
http://www.actionlyme.org/OPMC_CORRUPTION.htm
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>|
>Report Abuse
>|
>#5
>14 min ago
>
>The final reason the crooks caved was due to the showing of the Tribeca Pick,
"Under Our Skin," in which we all saw Yale's Eugene Shapiro lying
his face off about congenital Lyme:
>
http://www.actionlyme.org/Schoen.htm
>on top of his perjury at the Dr. Charles Ray Jones Medical Board Harassment
"Trial," where he said he "never saw a case of neurologic Lyme."
>
>OF COURSE NOT!! "Lyme Disease" now means late arthritis in a knee!!
>
>Certain people suing them (IDSA) were FURIOUS, and in the end, IDSA caved to
avoid criminal charges, as anyone can see with their own eyeballs,
since clearly
that's what IDSA's agreement was about with AG Blumenthal; they did
not
want criminal charges filed against them for homicide:
>
http://www.actionlyme.org/index.htm
>
>There's more data on the homepage.
>Scroll down until you find it.
>
>Kathleen M. Dickson
>Former Pfizer Analytical Chemist
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>|
>Report Abuse
>|
>#6
>9 min ago
>
>
http://www.actionlyme.org/ROCKEFELLER_UNIVERSITY.htm
>"The ability of the borrelia, especially tick-borne strains to persist
in the brain and in the eye after treatment with arsenic or with
penicillin or even
after apparent cure is well known (1). The persistence of treponemes
after treatment
of syphilis is a major area which currently requires additional study
(3,5,10,11).-Jay
Sanford, US Military Hospital, Bethesda
>
>(this textbook was edited by Russell Johnson who was a member of the board of
the ALDF.com)
>
>========
>Scary Space Aliens Apparently Trick Mark Klempner into reporting the reason
Lyme is incurable with intravenous ceftriaxone:
>
http://www.actionlyme.org/Mark_Klempner_Fibroblasts.htm
>Kathleen M Dickson
>Mystic, CT
>
>Reply »
>|
>Report Abuse
>|
>#7
>5 min ago
>
>=========
>Yale had an opportunity to study the adverse events caused by LYMErix. They
chose not to:
>
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
>
>In 1998, before the FDA even approved LYMErix, Yale's Robert Schoen (see
the top right of this scanned in image) says: Blood testing on a
vaccinated person
will need to be sent to a lab who tests for Lyme without the OspA and
B plasmid,
because A-B renders the blots unreadable. Yale knew this in 1995, but
they never
told the FDA that they had no way to tell whether or not LYMErix
prevented Lyme.
See the Persing patent in the RICO YouTube movie or here: The Central
RICO Patents.
>This same racketeering crime is also described here in an Aug 2005 complaint
to Homeland Stupidity Michael Jerkoff:
>
http://www.actionlyme.org/LYME_CORRUPTICUT.htm
>
>Kathleen M Dickson
>Join the community
>Mystic, CT
>
>1 min ago
>
>So, is "Lyme Disease" a late T-cell related arthritis in a knee, or
is it homicide?
>
http://www.actionlyme.org/ALS_&_Lyme_47%25.htm
>
>
>47% of men with Lou Gehrig's Disease in a Lyme endemic area have been exposed
to this spirochete which is a REAL number or "significant."
>
>Look at the antibodies in that report. They are not DEARBORN LYME:
>
http://www.actionlyme.org/CRYMEDISEASE_CHP3.htm
>
>THEY WOULD HAVE TESTED NEGATIVE and gone on to die as a result of IDSA's
Yale's and Allen Steere's scientific fraud.
>
>And surely die they do, since IDSA is clearly hysterical about this lawsuit,
which clearly could turn into something worse for them, like homicide
charges.
>
>Note that JJ Halperin is central to all this.
>
>Kathleen M. Dickson
>
>=========================================
>
>
courant.com/news/opinion/editorials/hc-digedlets0512.art2may12,0,3203498.story
>Courant.com
>LETTERS TO THE EDITOR
>No Conflict Of Interest
>
>May 12, 2008
>
>I'm disappointed and very concerned with the May 7 editorial "Conflicts
Taint Science."
>
>Although The Courant has the right to state its opinion, it is vital to make
sure the information provided to readers is accurate.
>
>The Vioxx case and others have generated a climate that makes it easy to believe
conflicts of interest in medicine are ubiquitous. But when these
conflicts do not
exist, such accusations serve only to wrongly undermine the public's
confidence
in medicine and the integrity of their physicians. The Infectious
Diseases Society
of America's Lyme disease guidelines recommend generic drugs and
generic diagnostic
tests. Panel members had no financial interests that could have
affected, or been
affected by, recommendations in the guidelines. In fact, by
recommending against
expensive, repeated, long-term antibiotic therapy, the panel members
denied themselves
and their colleagues an opportunity to generate a significant amount
of revenue.
>
>Furthermore, our panel members and the guidelines passed a stringent review
process before the guidelines were published.
>
>We greatly appreciate The Courant's understanding that the medical evidence
does not support long-term antibiotic therapy. The panel took extra
steps to consider
information provided by other organizations and individuals to ensure
the guidelines
were relevant, accurate and balanced. The recommendations reflect the
preponderance
of evidence that the risks of long-term antibiotic therapy — including
adverse reactions,
infections and the development of antibiotic-resistant bacteria — far
outweigh the
unproven benefits. And we are pleased that, by reaching an agreement
with state
Attorney General Richard Blumenthal, the controversy will remain in a
medical forum
where it belongs, and not in a courtroom.
>
>Following the agreement, the Infectious Diseases Society's Lyme disease
guidelines remain in place and still represent the best medical
science has to offer
patients with Lyme disease. Our top priority is to ensure that
patients diagnosed
with Lyme disease get medical treatment that will make them well.
>
>We voluntarily agreed to a singular review of our 2006 Lyme disease guidelines
by an independent panel of physicians and scientists because we hope
an independent
review will put the controversy to rest. We are confident our medical
recommendations
will be upheld.
>
>Donald Poretz, M.D.
>
>President Infectious Diseases Society of America Arlington, Va.
>
>Copyright © 2008, The Hartford Courant
>
>
>------------------------------------
>
>Yahoo! Groups Links
>
>
>
------------------------------------